KPW
TEVA icon

Kore Private Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

Kore Private Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$245K Sell
30,310
-120
-0.4% -$1.06K 0.04% 220
2022
Q2 		$229K Buy
30,430
+19,968
+191% +$174K 0.04% 255
2022
Q1 		$98K Buy
+10,462
New +$87.3K 0.01% 311
2020
Q3 		– Sell
-310
Closed -$3K – 994
2020
Q2 		$3K Hold
310
– – ﹤0.01% 1011
2020
Q1 		$3K Sell
310
-1,222
-80% -$12.5K ﹤0.01% 892
2019
Q4 		$15K Buy
+1,532
New +$13.7K ﹤0.01% 685
2019
Q2 		– Sell
-1,860
Closed -$29K – 723
2019
Q1 		$29K Hold
1,860
– – 0.01% 463
2018
Q4 		$29K Buy
+1,860
New +$38.1K 0.01% 445

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Kore Private Wealth's TEVA Position: Q3 2022 in Review

Kore Private Wealth reduced its Teva Pharmaceuticals (TEVA) stake by 0.39% in Q3 2022, selling an estimated $1.06K and leaving 30,310 shares worth $245K. The position accounts for 0.04% of the portfolio, ranked #220.

Kore Private Wealth first reported a position in TEVA in Q4 2018 and has held it in 8 quarters since. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Kore Private Wealth held 30,310 shares of Teva Pharmaceuticals worth $245K as of Q3 2022.
  • Kore Private Wealth sold 120 Teva Pharmaceuticals shares in Q3 2022, an estimated $1.06K.
  • Teva Pharmaceuticals made up 0.04% of Kore Private Wealth's portfolio in Q3 2022, its #220 holding.
  • Kore Private Wealth first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 8 quarters since.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.